Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
Objective: To evaluate the pharmacokinetics and HIV viral load response following initiation during the third trimester of pregnancy of zidovudine plus standard-dose lopinavir boosted with ritonavir (LPV/r), twice daily, until delivery for the prevention of mother-to-child transmission of HIV. Desig...
Saved in:
Main Authors: | Tim R. Cressey, Gonzague Jourdain, Boonsong Rawangban, Supang Varadisai, Rucha Kongpanichkul, Prapan Sabsanong, Prapap Yuthavisuthi, Somnuk Chirayus, Nicole Ngo-Giang-Huong, Nipunporn Voramongkol, Somsak Pattarakulwanich, Marc Lallemant |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77956232308&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/50921 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
by: Cressey T., et al.
Published: (2017) -
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
by: Tim R. Cressey, et al.
Published: (2018) -
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
by: Tim R. Cressey, et al.
Published: (2018) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
by: Chokephaibulkit K., et al.
Published: (2014)